BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 9314611)

  • 1. Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.
    Davies NM; Anderson KE
    Clin Pharmacokinet; 1997 Sep; 33(3):184-213. PubMed ID: 9314611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of naproxen.
    Davies NM; Anderson KE
    Clin Pharmacokinet; 1997 Apr; 32(4):268-93. PubMed ID: 9113437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.
    Davies NM; McLachlan AJ; Day RO; Williams KM
    Clin Pharmacokinet; 2000 Mar; 38(3):225-42. PubMed ID: 10749518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of ibuprofen. The first 30 years.
    Davies NM
    Clin Pharmacokinet; 1998 Feb; 34(2):101-54. PubMed ID: 9515184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of flurbiprofen and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1995 Feb; 28(2):100-14. PubMed ID: 7736686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1996 Nov; 31(5):331-47. PubMed ID: 9118583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of oxaprozin.
    Davies NM
    Clin Pharmacokinet; 1998 Dec; 35(6):425-36. PubMed ID: 9884815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
    Davies NM
    Clin Pharmacokinet; 1997 Dec; 33(6):404-16. PubMed ID: 9435990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of sulindac. A dynamic old drug.
    Davies NM; Watson MS
    Clin Pharmacokinet; 1997 Jun; 32(6):437-59. PubMed ID: 9195115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.
    Skjodt NM; Davies NM
    Clin Pharmacokinet; 1998 Jun; 34(6):421-8. PubMed ID: 9646006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of ketoprofen and its enantiomers.
    Jamali F; Brocks DR
    Clin Pharmacokinet; 1990 Sep; 19(3):197-217. PubMed ID: 2203580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac pharmacokinetic meta-analysis and dose recommendations for surgical pain in children aged 1-12 years.
    Standing JF; Tibboel D; Korpela R; Olkkola KT
    Paediatr Anaesth; 2011 Mar; 21(3):316-24. PubMed ID: 21276131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal Behavior of Weakly Acidic BCS Class II Drugs in Man--Case Study of Diclofenac Potassium.
    Van Den Abeele J; Brouwers J; Mattheus R; Tack J; Augustijns P
    J Pharm Sci; 2016 Feb; 105(2):687-696. PubMed ID: 26375734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.
    Manvelian G; Daniels S; Gibofsky A
    Postgrad Med; 2012 Jan; 124(1):117-23. PubMed ID: 22314121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
    Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
    Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study.
    Scallion R; Moore KA
    Clin Ther; 2009 Oct; 31(10):2233-41. PubMed ID: 19922894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug.
    Davies NM; Skjodt NM
    Clin Pharmacokinet; 1999 Feb; 36(2):115-26. PubMed ID: 10092958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsynovial drug distribution: synovial mean transit time of diclofenac and other nonsteroidal antiinflammatory drugs.
    Elmquist WF; Chan KK; Sawchuk RJ
    Pharm Res; 1994 Dec; 11(12):1689-97. PubMed ID: 7899229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.